Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination rabies immunoglobulin formulation vs human rabies immunoglobulin in healthy adults
CTR20200829Phase 2Completed
- Sponsor
- NCPC New Drug Research & Development
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of rabies immune globulin (human) in rabies, sponsored by NCPC New Drug Research & Development. Started Jun 2020; status: completed.
02
Drugs
rabies immune globulin (human)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20200829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200829.